RxDoctor Payments Data

Brianne Cohen, NP

Nurse Practitioner · Midlothian, VANPI 1205486354

Payments from drug & device makers

$3,804in general payments, 2019–2025

Across 67 payments — averaging $56.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Rigel Pharmaceuticals, Inc.$299
  • Amgen$243
  • Medtronic$120
  • Puma Biotechnology, Inc.$70
  • Pfizer$61
  • plus $291 from 13 others

What the payments were for

  • Food & beverage$1,11029%
  • Education$612%
  • Other$2,63269%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,804 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$45,950
Medicare patients
233
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib57$883,289
KisqaliRibociclib Succinate26$395,776
BraftoviEncorafenib12$180,077
EliquisApixaban47$31,174
Exemestane53$10,354
Anastrozole505$9,857
XareltoRivaroxaban13$6,912
Tamoxifen Citrate118$3,099
Letrozole109$2,605
Duloxetine Hcl102$2,092
Potassium Chloride46$1,227
Oxybutynin Chloride ErOxybutynin Chloride24$702
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine22$547
Prochlorperazine Maleate13$526
Gabapentin63$444

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerIbrance, Eliquis$61$914,463104 claims
NovartisKisqali$2,720$395,77626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →